1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroi

Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroi

  1. Electrolingus
    OBJECTIVE To determine the cost utility of medical co-prescription of heroin compared with methadone maintenance treatment for chronic, treatment resistant heroin addicts.

    DESIGN Cost utility analysis of two pooled open label randomised controlled trials.
    SETTING Methadone maintenance programmes in six cities in the Netherlands.
    PARTICIPANTS 430 heroin addicts.
    INTERVENTIONS Inhalable or injectable heroin prescribed over 12 months. Methadone (maximum 150 mg a day) plus heroin (maximum 1000 mg a day) compared with methadone alone (maximum 150 mg a day). Psychosocial treatment was offered throughout.
    MAIN OUTCOME MEASURES One year costs estimated from a societal perspective. Quality adjusted life years (QALYs) based on responses to the EuroQol EQ-5D at baseline and during the treatment period.
    RESULTS Co-prescription of heroin was associated with 0.058 more QALYs per patient per year (95% confidence interval 0.016 to 0.099) and a mean saving of http://www.bmj.com/math/euro.gif12 793 (£8793, $16 122) (http://www.bmj.com/math/euro.gif1083 to http://www.bmj.com/math/euro.gif25 229) per patient per year. The higher programme costs (http://www.bmj.com/math/euro.gif16 222; lower 95% confidence limit http://www.bmj.com/math/euro.gif15 084) were compensated for by lower costs of law enforcement (- http://www.bmj.com/math/euro.gif4129; upper 95% confidence limit - http://www.bmj.com/math/euro.gif486) and damage to victims of crime (- http://www.bmj.com/math/euro.gif25 374; upper 95% confidence limit - http://www.bmj.com/math/euro.gif16 625). The results were robust for the use of national EQ-5D tariffs and for the exclusion of the initial implementation costs of heroin treatment. Completion of treatment is essential; having participated in any abstinence treatment in the past is not.

    CONCLUSIONS Co-prescription of heroin is cost effective compared with treatment with methadone alone for chronic, treatment resistant heroin addicts.

    Discussion Thread